R3i-Stiftung - Residual Risk Reduction Initiative

Existing

CH27070030171

Die Stiftung bezweckt, zur Förderung des Allgemeinwohls weltweit Anstrengungen zu unternehmen, das trotz kunstgerechter Behandlung verbleibende Restrisiko makro- und mikrovaskulärer Vorfälle bei Herz-Kreislauf- und Diabetes-Patienten zu reduzieren.

Basic Information

Legal FormFoundation
SummaryThe company's purpose is to reduce the risk of macro- and microvascular events in patients with heart, circulatory, and diabetes conditions. This suggests that the company may be involved in manufacturing medical devices or providing healthcare services.

Address

Company NameR3i-Stiftung - Residual Risk Reduction Initiative
Postal Code4052
CityBasel
CantonBasel-Stadt
CountrySwitzerland

Business Activities

Human Health and Social Work ActivitiesManufacturing

Contact Information

Additional Information

Registered20.9.2025
Commercial Register EntryCH27070030171
Last Updated13.12.2025